What counts as a moon? Huge ‘exosatellite’ sparks debate
Trending
- After long fight, England to provide AstraZeneca breast cancer drug
- Early-adulthood body mass index, mammographic density and post-menopausal breast cancer risk: a mediation analysis
- Guy’s Hospital pilots prostate cancer treatment
- New mesothelioma drug turns cancer’s own defenses against it
- Women in England with incurable breast cancer to get life-extending drug on NHS | Breast cancer
- m⁶A-dependent TRIM71 stabilization by YTHDC1 promotes hepatoblastoma progression
- Psychosocial Support for Treatment-Related Challenges in Relapsed/Refractory Multiple Myeloma
- Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization
Thursday, September 17
